We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Real-Time Apneic Screening Device

By Biotechdaily staff writers
Posted on 12 Jan 2007
A small, easy-to-use, and unobtrusive device allows screening for apneic events in persons who may be suspected of having obstructive sleep apnea (OSA). More...


The battery-powered RUSleeping real time screening (RTS) device consists of a base unit and a nasal cannula. Respiratory airflow pressure is sensed via the cannula and the device starts to record apneic events. When breathing decreases by 50% or more for 10 seconds or longer, it is considered an apneic event and is recorded on the liquid crystal display (LCD) readout. The device is convenient to operate and can be re-used. No accessory equipment, software, or electrical outlet is needed.

Based upon a patient's at-home overnight score, physicians can interpret if the patient is a likely candidate for an immediate polysomnogram (PSG). Sleep lab physicians can provide the RUSleeping RTS to patients to pre-screen at home for OSA before the patient is seen for an in-lab PSG. By being presented with objective data regarding their apneic events, patients may more readily accept the need for a complete PSG and consequent treatment, if needed. The RUSleeping RTS is manufactured by Respironics (Murrysville, PA, USA).

"The RUSleeping RTS device is much less cumbersome and expensive than many other screening devices. It is a quick and simple tool for busy clinicians who have patients presenting with subjective symptoms of OSA,” said Respironics product manager Rick Herrle. "This may help bring patients one step closer to diagnosis and treatment, which is what good patient outcomes are all about.”



Related Links:
Respironics

New
Gold Member
Latex Test
SLE-Latex Test
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.